Quidel | QDEL - Current Liabilities


Quidel reported $962.4M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Agilent USD 2.27B 35M Mar/2026
Avanos Medical USD 131.2M 34M Mar/2026
Becton, Dickinson and Co. USD 8.51B 254M Mar/2026
Bruker USD 1.36B 75.9M Mar/2026
Cerus USD 100.8M 12.37M Dec/2025
Charles River Laboratories USD 1.09B 26.61M Mar/2026
Danaher USD 7.46B 653M Mar/2026
Haemonetics USD 282.6M 257.27M Mar/2026
Illumina USD 1.57B 19M Mar/2026
IQVIA Holdings USD 8.33B 9M Mar/2026
Merit Medical Systems USD 216.87M 22.89M Mar/2026
Mettler Toledo International USD 1.11B 89.76M Mar/2026
Myriad Genetics USD 130.2M 3.6M Mar/2026
Neogen USD 150.6M 3.55M Dec/2025
OraSure Technologies USD 44.08M 4.29M Mar/2026
Pacific Biosciences Of California USD 65.36M 7.48M Mar/2026
Quidel USD 962.4M 3.7M Mar/2026
Revvity USD 1.24B 92.6M Mar/2026
STAAR Surgical USD 60.99M 7.51M Mar/2026
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Waters USD 1.24B 11.8M Dec/2025